RPRiccardo Pellegrino

Riccardo Pellegrino

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Riccardo Pellegrino has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Vito Brusasco

    Dipartimento di Medicina Interna e Specialità Mediche, Scuola di Scienze Mediche e Farmaceutiche, Università di Genova, Genova, Italy

    5 shared publications
  • Andrea Antonelli

    Allergology and Respiratory Physiopathology S. Croce e Carle Hospital Cuneo Italy

    2 shared publications
  • Carlo Gulotta

    Respiratory Disease 1 S.Luigi Hospital Orbassano Italy

    2 shared publications
  • Emanuele Crimi

    Respiratory Physiopathology Internal Medicine Department University of Genova Genova Italy

    2 shared publications
  • Roberto Torchio

    Respiratory Function and Sleep Laboratory S.Luigi Hospital Orbassano Italy

    2 shared publications
  • V Brusasco

    2 shared publications

Latest Publications

  • Rebuttal From Drs Pellegrino and Brusasco

    by Riccardo Pellegrino, Vito Brusasco


  • Open Access

    Asthma and respiratory physiology: Putting lung function into perspective

    by Giuseppe Francesco Sferrazza Papa, Giulia Michela Pellegrino, Riccardo Pellegrino

    Bronchial asthma is a chronic disease characterized by airway hyperresponsiveness, airway inflammation and remodelling. The hypothesis that the illness is inflammatory in nature has recently been challenged by studies showing that airway smooth muscle (ASM) plays a more important role than previously thought. For example, it is now known that in asthma patients, ASM proliferates more and faster than in healthy subjects, carries intrinsic defects and exhibits impaired relaxation, increased velocity of shortening, plastic adaptation to short length and perturbed equilibrium of actin‐to‐myosin during cycling. Similar conclusions can be drawn from studies on airway mechanics. For instance, in asthma, abnormal ASM contributes to limiting the response to deep lung stretching and accelerates the return of bronchial tone to baseline conditions, and contributes to increased airway stiffness. Upon stimulation, ASM causes airway narrowing that is heterogeneous across the lung and variable over time. This heterogeneity leads to patchy ventilation. Experimental studies have shown that patchy ventilation may precipitate an asthma attack, and inability to maintain bronchial tone control over time can predict the occurrence of bronchospastic attacks over a matter of a few days. To improve our knowledge on the pathogenesis of asthma, we believe that it is necessary to explore the disease within the framework of the topographical, volume and time domains of the lung that play an important role in setting the severity and progression of the disease. Application of the forced oscillation technique and multiple breath nitrogen washout may, alone or in combination, help address questions unsolvable until now.


  • Dependence of bronchoconstrictor and bronchodilator responses on thoracic gas compression volume

    by Riccardo Pellegrino, Andrea Antonelli, Emanuele Crimi, Carlo Gulotta, Roberto Torchio, Luca Dutto, Ole F. Pedersen, Vito Brusasco

    During forced expiration, alveolar pressure (PALV ) increases and intrathoracic gas is compressed. Thus, 1-s forced expiratory volume measured by spirometry (FEV1-sp ) is smaller than 1-s forced expiratory volume measured by plethysmography (FEV1-pl ). Thoracic gas compression volume (TGCV) depends on the amount of gas within the lung when expiratory flow limitation occurs in the airways. We therefore tested the hypothesis that bronchoconstrictor and bronchodilator responses using FEV1-sp are biased by height and gender, which are major determinants of lung volume


  • Open Access

    Mechanical correlates of dyspnea in bronchial asthma

    by Andrea Antonelli, Emanuele Crimi, Alessandro Gobbi, Roberto Torchio, Carlo Gulotta, Raffaele Dellaca, Giorgio Scano, Vito Brusasco, Riccardo Pellegrino

    We hypothesized that dyspnea and its descriptors, that is, chest tightness, inspiratory effort, unrewarded inspiration, and expiratory difficulty in asthma reflect different mechanisms of airflow obstruction and their perception varies with the severity of bronchoconstriction. Eighty‐three asthmatics were studied before and after inhalation of methacholine doses decreasing the 1‐sec forced expiratory volume by ~15% (mild bronchoconstriction) and ~25% (moderate bronchoconstriction). Symptoms were examined as a function of changes in lung mechanics. Dyspnea increased with the severity of obstruction, mostly because of inspiratory effort and chest tightness. At mild bronchoconstriction, multivariate analysis showed that dyspnea was related to the increase in inspiratory resistance at 5 Hz (R5) (r2 = 0.10, P = 0.004), chest tightness to the decrease in maximal flow at 40% of control forced vital capacity, and the increase in R5 at full lung inflation (r2 = 0.15, P = 0.006), inspiratory effort to the temporal variability in R5‐19 (r2 = 0.13, P = 0.003), and unrewarded inspiration to the recovery of R5 after deep breath (r2 = 0.07, P = 0.01). At moderate bronchoconstriction, multivariate analysis showed that dyspnea and inspiratory effort were related to the increase in temporal variability in inspiratory reactance at 5 Hz (X5) (r2 = 0.12, P = 0.04 and r2 = 0.18, P < 0.001, respectively), and unrewarded inspiration to the decrease in X5 at maximum lung inflation (r2 = 0.07, P = 0.04). We conclude that symptom perception is partly explained by indexes of airway narrowing and loss of bronchodilatation with deep breath at low levels of bronchoconstriction, but by markers of ventilation heterogeneity and lung volume recruitment when bronchoconstriction becomes more severe.


  • Open Access

    Unfolding the mechanisms of progression of pulmonary emphysema in COPD

    by Riccardo Pellegrino, Andrea Antonelli

    Until a quarter of a century ago, diagnosing pulmonary emphysema in clinical practice was a very difficult task, as the definition of the disease was based only on the pathological criteria of destruction of the parenchyma distal to the terminal bronchioles in the absence of inflammation and/or fibrosis [1]. Lung function tests could be of help but this was only possible when airflow obstruction was severe, lung volumes increased above normal and diffusing capacity of the lung very low, i.e. too late to identify the disease in the early stages. Similarly, chest radiography could be of help for this purpose but only when lung fields were hyperlucent with blebs and no or few arteries, the diaphragm was flat, and anteroposterior diameters were increased. Again, this was when the disease was too advanced. A major breakthrough occurred with the advent of high-resolution computed tomography (HRCT), a tool that proved to be very sensitive in assessing the pathology on its centrilobular, panlobular and paraseptal features, and its distribution across the lungs [2, 3]. The results were so impressive that the technique was soon widely used in both clinical practice and research. In addition to assisting in the clinical diagnosis of the disease condition, HRCT brought major advancements as for the pathogenesis of the chronic obstructive pulmonary disease (COPD), and nowadays plays a crucial role with respect to lung volume reduction surgery [4] and transplantation [5]. Recent studies have focused on HRCT as a tool to assess the progression of the disease. Most of them have been conducted in α1-antitrypsin deficiency with the aim of identifying the lung densitometry parameters that best reflect the progression of the disease [6] compared with classical functional parameters, such as forced expiratory volume in …


  • Open Access

    Quality control of spirometry: a lesson from the BRONCUS trial

    by R. Pellegrino, M. Decramer, C. P. O. van Schayck, P. N. R. Dekhuijzen, T. Troosters, C. van Herwaarden, D. Olivieri, M. Del Donno, W. De Backer, I. Lankhorst, et al.

    This report describes the quality control programme used within the Bronchitis Randomized on N-acetylcysteine (NAC) Cost-Utility Study, a trial designed to assess the decline in lung function, exacerbation rate, health status, and cost-effectiveness with NAC or a placebo in 523 patients with chronic obstructive pulmonary disease over a 3-yr period.Spirometry was scored from 0 (worst quality) to 6 (best quality). The mean score of 314 spirometries from 243 patients evaluated during the trial was 5.63±0.83. Linear regression analysis of the scores of 47 participating centres plotted against the time at which spirometries were performed yielded an intercept of 5.7±0.5 and a slope of -0.0001±0.001, which suggests that the initial high quality was maintained over time.Retrospective examination of a further 345 postbronchodilator spirometries from 208 patients with a forced expiratory volume at one second exceeding the mean individual value recorded over the study in excess of 20% revealed a slightly lower quality of the start-of-test manoeuvre compared with the 314 spirometries.In conclusion, these findings would suggest that the quality control programme is likely to have helped achieve and maintain long-term spirometry performance in the Bronchitis Randomized on N-acetylcysteine (NAC) Cost-Utility Study trial. Special care should be paid to the spirometries whose forced expiratory volume in one second values exceed the mean value.


  • Assessing Airflow Obstruction: When Everything Is Not So Obvious

    by Riccardo Pellegrino, Vito Brusasco


    • 26 November 2003
      • Vol. 59  (2) , 150-4

    The effect of inhaled furosemide and acetazolamide on bronchoconstriction induced by deep inspiration in asthma.

    by L Spicuzza, N Ciancio, R Pellegrino, S Bellofiore, R Polosa, F L Ricciardolo, V Brusasco, G U Di Maria

    In some asthmatics deep inspiration causes a sustained bronchoconstration, which is dependent on Ca2+ uptake. Inhaled diuretics protect against bronchoconstriction induced by a variety of indirect stimuli, by inhibiting the ionic fluxes involving Ca2+ uptake across the cell membrane of airway epithelium. The aim of this study was therefore to investigate the protective effect of inhaled furosemide on the bronchoconstriction induced by deep inspiration in asthma and to compare it with the effect of acetazolamide, an inhibitor of carbonic anhydrase devoid of effect on ion cotransport but possessing inhibitory effects on chloride ion influx and Na+/K+ exchange. The study was carried out on three different study days according to a randomized, double-blind, placebo-controlled, crossover design. Nine non smoking asthmatic subjects first performed a series of 9 controlled deep inspirations to TLC followed by forced expirations to RV within 20 min, which caused a decrease of FEV1 > 20% from baseline. Two hours later, the subjects inhaled either furosemide (40 mg), or acetazolamide (500 mg), or saline (placebo) in random order, and then two more deep-inspiration challenges were performed after 30 and 140 mins. The progressive percent decrement of FEV1 caused by deep-inspiration challenge was taken as an index of bronchoconstriction. Bronchoconstriction was significantly blunted at 30 mins, but not 140 mins, after inhaling furosemide (p < 0.01) or acetazolamide (p < 0.05) compared to control. We interpret these results as due to a modulation of ionic fluxes across the smooth muscle cell membrane afforded by inhaled furosemide and acetazolamide.


    • 1 December 1994
      • Vol. 49  (5) , 439-43

    Lung volumes and expiratory flow during bronchoconstriction in asthma.

    by R Pellegrino, V Brusasco

    Bronchial asthma is characterized by excessive airway narrowing and hyperinflation. In this review, the mechanisms linking the increases of functional residual capacity (FRC) and residual volume (RV) to reduced airway calibre are analysed. The authors have shown that the increase in FRC is closely associated with the occurrence of flow limitation, i.e. the achievement of maximum flow during tidal volume; whereas, the increase in RV can be modulated by the magnitude of the bronchodilator effect of the deep inhalation during induced bronchoconstriction. It can be speculated that flow limitation contributes to the increase in FRC through a reflex mechanism; whereas, the increase in RV depends on the site of airway narrowing, which in turn determines the relationship between airway and parenchymal properties.